Riastap 1000 mg (Fibrinogen (Human) POWDER FOR SOLUTION) 1000 MG

RIASTAP 1000 MG is a fibrinogen (human) powder for solution used for intravenous administration. It is designed to support clotting in certain medical conditions. This product is manufactured by CSL Behring Canada Inc.

Strength

1000 MG

Pack Size

50ML

Manufacturer / TM Owner

CSL BEHRING CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RIASTAP 1000 MG is generally used to help manage bleeding disorders where fibrinogen levels are low. It is often utilized in situations where rapid clotting is necessary. The primary use of fibrinogen (human) is to support the body's natural clotting process, which can be crucial in various medical scenarios.

Side Effects

When administered, RIASTAP 1000 MG works to enhance the clotting process. Common effects may include improved clotting at the site of injury or procedure. As with any medical product, individual responses can vary.

Precautions & Warnings

RIASTAP 1000 MG should be handled with care and stored as per the manufacturer's instructions. It is important to follow medical guidance when using this product. Always inform healthcare providers of any allergies or sensitivities before administration.

Avoid Interactions

RIASTAP 1000 MG may interact with other medications or substances. It is advisable to discuss all current medications with a healthcare provider before use. Specific interactions can vary based on individual health conditions.

Frequently Asked Questions

RIASTAP 1000 MG is used to support clotting in situations where fibrinogen levels are low, such as in certain bleeding disorders.

RIASTAP 1000 MG is administered intravenously after being prepared as a solution from the powder form.

Common effects may include improved clotting at the site of injury or procedure, supporting the body's natural clotting process.

Yes, it is important to handle and store RIASTAP 1000 MG as per the manufacturer's instructions and to follow medical guidance.

Yes, RIASTAP 1000 MG may interact with other medications, so it is advisable to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.